Phenomenology, aetiology and treatment of schizophrenia

Novartis Foundation Symposium

Volumn 289, Issue , 2008, Pages 4-16

  Javitt, Daniel C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH PROMOTOR; N METHYLASPARTIC ACID;

ARTICLE; COGNITIVE DEFECT; DRUG ANTAGONISM; DRUG POTENTIATION; HEARING DISORDER; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SCHIZOPHRENIA;

COGNITION DISORDERS; GROWTH SUBSTANCES; HEARING DISORDERS; HUMANS; N-METHYLASPARTATE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 48849094673     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (36)

1. Adler CM, Malhotra AK, Elman I et al 1999 Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry 156:1646-1649
2. Balla A, Koneru R, Smiley J, Sershen H, Javitt DC 2001 Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release. Neuropsychopharmacology 25:157-164
3. Bilder RM, Goldman RS, Robinson D et al 2000 Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 157:549-559
4. Brekke J, Kay DD, Lee KS, Green MF 2005 Biosocial pathways to functional outcome in schizophrenia. Schizophr Res 80:213-225
5. Butler PD, Gur RC, Jalbkowcski M et al 2005a Visual processing impairment and emotion recognition dysfunction in schizophrenia. Schizophr Bull 31:352
6. Butler PD, Zemon V, Schechter I et al 2005b Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch Gen Psychiatry 62:495-504
7. Butler PD, Martinez A, Foxe JJ et al 2007 Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments. Brain 130:417-430
8. Carlsson A 1988 The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-186
9. Chen CM, Lakatos P, Shah AS et al 2007 Functional anatomy and interaction of fast and slow visual pathways in macaque monkeys. Cereb Cortex 17:1561-1569.
10. Doniger GM, Foxe JJ, Murray MM, Higgins BA, Javitt DC 2002 Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia. Arch Gen Psychiatry 59:1011-1020
11. Ho BC, Andreasen NC, Nopoulos P, Fuller R, Arndt S, Cadoret RJ 2005 Secondary prevention of schizophrenia: utility of standardized scholastic tests in early identification. Ann Clin Psychiatry 17:11-18
12. Javitt DC 2000 Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia. Audiol Neurootol 5:207-215
13. Javitt DC 2006 Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients. Curr Opin Psychiatry 19:151-157
14. Javitt DC, Zukin SR 1991 Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
15. Javitt DC, Doneshka P, Grochowski S, Ritter W 1995 Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia. Arch Gen Psychiatry 52:550-558
16. Javitt DC, Sershen H, Hashim A, Lajtha A 1997 Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide. Neuropsychopharmacology 17:202-204
17. Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H 2004 Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists. Neuropsychopharmacology 29:300-307
18. Kegeles LS, Abi-Dargham A, Zea-Ponce Y et al 2000 Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry 48:627-640
19. Kim D, Wylie G, Pasternak R, Butler PD, Javitt DC 2006 Magnocellular contributions to impaired motion processing in schizophrenia. Schizophr Res 82:1-8
20. Kring AM, Barrett LF, Gard DE 2003 On the broad applicability of the affective circumplex: representations of affective knowledge among schizophrenia patients. Psychol Sci 14:207-214
21. Krystal JH, Perry EB Jr, Gueorguieva R et al 2005 Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62:985-994
22. Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA 2001 Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25:455-467
23. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R 1999 Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46:56-72
24. Leitman DI, Foxe JJ, Butler PD, Saperstein A, Revheim N, Javitt DC 2005 Sensory contributions to impaired prosodic processing in schizophrenia. Biol Psychiatry 58:56-61
25. Leitman DI, Ziwich R, Pasternak R, Javitt DC 2006 Theory of Mind (ToM) and counterfactuality deficits in schizophrenia: misperception or misinterpretation? Psychol Med 36:1075-1083
26. Leitman DI, Hoptman MJ, Foxe JJ et al 2007 The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents. Am J Psychiatry 164:474-482
27. Lencz T, Smith CW, McLaughlin D et al 2006 Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry 59:863-871
28. Linn GS, O'Keeffe RT, Lifshitz K, Schroeder C, Javitt DC 2007 Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine. Psychopharmacology (Berl) 192:27-38
29. March L, Cienfuegos A, Goldbloom L, Ritter W, Cowan N, Javitt DC 1999 Normal time course of auditory recognition in schizophrenia, despite impaired precision of the auditory sensory ("echoic") memory code. J Abnorm Psychol 108:69-75
30. Parwani A, Weiler MA, Blaxton TA et al 2005 The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology (Berl) 183:265-274
31. Rabinowicz EF, Silipo G, Goldman R, Javitt DC 2000 Auditory sensory dysfunction in schizophrenia: imprecision or distractibility? Arch Gen Psychiatry 57:1149-1155
32. Revheim N, Butler PD, Schechter I, Jalbrzikowski M, Silipo G, Javitt DC 2006 Reading impairment and visual processing deficits in schizophrenia. Schizophr Res 87:238-245
33. Strous RD, Cowan N, Ritter W, Javitt DC 1995 Auditory sensory ("echoic") memory dysfunction in schizophrenia. Am J Psychiatry 152:1517-1519
34. Umbricht D, Krljes S 2005 Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 76:1-23
35. Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC 2000 Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57:1139-1147
36. Woods SW, Thomas L, Tully E et al 2004 Effects of oral glycine in the schizophrenia prodrome. Schizophr Res 70:79